A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities
Pathological angiogenesis is mainly initiated by the binding of abnormal expressed vascular endothelial growth factors (VEGFs) to their receptors (VEGFRs). Blocking the VEGF/VEGFR interaction is a clinically proven treatment in cancer. Our previous work by epitope scan had identified cyclic peptides...
Saved in:
Main Authors: | Lei Wang (Author), Meng Xu (Author), Haofeng Hu (Author), Lun Zhang (Author), Fei Ye (Author), Jia Jin (Author), Hongming Fang (Author), Jian Chen (Author), Guiqian Chen (Author), Sylvain Broussy (Author), Michel Vidal (Author), Zhengbing Lv (Author), Wang-Qing Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
by: Lei Wang, et al.
Published: (2024) -
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease
by: Sylvain Broussy
Published: (2024) -
Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)
by: Sylvain Broussy, et al.
Published: (2020) -
Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy
by: Bao Li, et al.
Published: (2024) -
A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents
by: Leilei Guo, et al.
Published: (2022)